深圳南山区举办"X-Day"西丽湖路演生物医药专场，汇集了200余位投资机构代表、科创项目负责人及行业专家1。本次活动探讨了生物医药产业的新周期发展机遇，参会投资界人士表示行业已进入强劲复苏阶段，资本投向正从同质化靶点向差异化创新和平台型技术转变1。路演现场共有6个创新项目进行精品展示，涵盖创新药、细胞基因治疗、AI赋能研发等前沿领域1。
南山区生物医药产业发展势头稳健。2025年该区医药与医疗器械产业增加值达到146.4亿元，同比增长6.0%1。截至2026年6月，近五年全区新增临床试验109个、医疗器械批准数量1266个1。整个行业融资活动也呈现向好态势，今年上半年国内BD交易金额同比翻倍1。
作为创新服务平台，"X-Day"西丽湖路演社已连续举办20场主题路演，累计助力60家企业获得股权投资超33.36亿元，35家企业获得银行授信超11.52亿元1。该路演社将继续深化创新生态建设，10月8日将在北京清华大学举办AI for Science专场1。
Shenzhen's Nanshan District hosted the "X-Day" Xili Lake Roadshow biotech and pharmaceutical session, bringing together more than 200 representatives from investment institutions, science and technology innovation project leaders, and industry experts to discuss development opportunities in a new industry cycle.1 Investment professionals at the event indicated that the sector has entered a phase of strong recovery, with capital shifting preference from homogeneous drug targets toward differentiated innovation and platform-based technologies.1
Six innovative projects underwent featured roadshow presentations, showcasing cutting-edge achievements in innovative pharmaceuticals, cellular and gene therapy, and AI-enabled research and development.1 Domestic business development transaction volumes in the first half of this year doubled year-over-year.1 The pharmaceutical and medical device industry in Nanshan District reached an added value of 146.4 billion yuan in 2025, representing a 6.0% year-over-year increase.1
By June 2026, Nanshan District has added 109 clinical trials and approved 1,266 medical devices over the past five years.1 The "X-Day" Xili Lake Roadshow series has continuously hosted 20 themed roadshows to date, facilitating equity investments exceeding 3.336 billion yuan for 60 enterprises and securing bank credit facilities surpassing 1.152 billion yuan for 35 enterprises.1 The series will continue with an AI for Science session scheduled for October 8 at Tsinghua University in Beijing.1
评论
还没有评论，欢迎留下第一条。